Biological Dynamics and Oregon Health & Science University Collaborate on Early-Stage Pancreatic Cancer Detection Study

/

Biological Dynamics, Inc., a company developing and commercializing its exosome-isolation ExoVerita™ platform for early disease diagnostics and other applications, announced its collaboration with the Brenden-Colson Center for Pancreatic Care at Oregon Health & Science University (OHSU) to study its ExoVita™ Pancreas assay. The Brenden-Colson Center has a robust, integrated clinical-translational interface to drive innovative patient care and nourish scientific collaborations. 

Read More

Biological Dynamics and the OHSU Knight Cancer Institute Announce Cancer Diagnostic Research Collaboration

/ Biological Dynamics/

SAN DIEGO and PORTLAND, Oregon, September 28, 2017 -- Biological Dynamics, Inc., a developer of innovative oncology-focused molecular diagnostic products, and the Knight Cancer Institute at Oregon Health & Science University (OHSU), a national leader in translational oncology research, have initiated a collaboration to advance early cancer detection. The research will take place at the OHSU Cancer Early Detection Advanced Research (CEDAR) Center in Portland, with Biological Dynamics providing CEDAR Center researchers with early technology access to its NanoVerita™ and ExoVerita™ platforms.

Read More